Øystein Åmellem

Director, Cell Bio  • Thermo Fisher Scientific Inc

Øystein’s professional experience is derived from different leadership positions in R&D, Product Management and Business for over 22 years in Thermo Fisher Scientific, he is responsible for development and commercialization of products and services for the cell therapy market. His scientific training is in the field of molecular cell biology and he received a PhD from the University of Oslo. Øystein’s academic career focused on the study of physiological & molecular mechanisms of tumor cell growth and the development of novel therapies for the treatment of solid tumors in collaboration with Norsk Hydro.

Also Speaking

John Schick

Vice President, Global Market Access and Policy • Instil Bio

Michael Mercaldi

Senior Director, Downstream Process Development • Homology Medicines

Josh Ludwig

Global Director, Commercial Operations • ScaleReady

Event Info


Fun Run